Head-to-head decision matrix
Flare-timeline photo journal for eczema and psoriasis patients best fits the Operator Builder (48/100 fit), while Recovery-percentile tracker for orthopedic surgery patients best fits the Research Strategist (36/100 fit). Choose by the founder advantage you can actually bring to the first validation sprint.
Patients struggle to recall when flares started, what triggered them, and whether treatment is working, so dermatology visits rely on vague memory instead of dated photo evidence.
After orthopedic surgery, patients cannot tell whether their pain, swelling, and stiffness are normal, so they flood surgeon offices with 'is this normal?' calls while staff have no objective benchmark to reassure or escalate.
Validation criteria
Bars use the existing report visual scale, with each criterion scored out of 10.
Demand looks thin because the report has 2 source-backed signal(s), an editorial confidence of 62/100, and a defined buyer in Chronic skin condition self-management.
Demand looks thin because the report has 2 source-backed signal(s), an editorial confidence of 54/100, and a defined buyer in Orthopedic post-operative recovery tracking.
Problem severity is promising when the buyer pain, customer value, and dream-outcome scores are combined.
Problem severity is thin when the buyer pain, customer value, and dream-outcome scores are combined.
Willingness to pay is thin; the model has a monetization hypothesis, but it must still be proven through paid pilots or explicit pricing objections.
Willingness to pay is weak; the model has a monetization hypothesis, but it must still be proven through paid pilots or explicit pricing objections.
Competitive room is reduced by 2 recorded alternative(s); the wedge must stay narrow and differentiated.
No source-backed direct match is recorded yet, so saturation risk is treated as unknown rather than proof of novelty.
Feasibility is strong for a low build if the MVP is limited to the first measurable workflow.
Feasibility is weak for a high build if the MVP is limited to the first measurable workflow.
Revenue: $250K-$2M ARR potential if the wedge proves budget urgency and becomes a recurring workflow.
GTM: Start with manual concierge output, direct outreach, and community proof before paid acquisition.
Execution: Execution is low; the main constraint is staying narrow enough for a first proof loop.
Revenue: $250K-$2M ARR potential if the wedge proves budget urgency and becomes a recurring workflow.
GTM: Start with manual concierge output, direct outreach, and community proof before paid acquisition.
Execution: Execution is high; the main constraint is staying narrow enough for a first proof loop.
Flare-timeline photo journal for eczema and psoriasis patients best fits the Operator Builder (48/100 fit), while Recovery-percentile tracker for orthopedic surgery patients best fits the Research Strategist (36/100 fit). Choose by the founder advantage you can actually bring to the first validation sprint.